Johnson & Johnson’s spine robot: What we know so far

Velys Spine, the robot from Johnson & Johnson’s DePuy Synthes, is slated for a 2025 commercial release.

Advertisement

Here’s what we know about the robot so far:

1. Johnson & Johnson leaders first announced plans for the spine robot at the 2022 Wells Fargo Healthcare Conference. 

2. Velys Spine earned FDA 510(k) clearance in August. It was developed in partnership with eCential Robotics.

3. Velys Spine is a dual-use robotics and standalone navigation platform. It has pathology-specific workflows and is compatible with DePuy Synthes’ portfolio of spine implants.

4. The robot is indicated for planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar and sacroiliac spine.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Robotics

Advertisement

Comments are closed.